Church & Dwight (NYSE:CHD) Price Target Raised to $93.00

Church & Dwight (NYSE:CHD) had its price target increased by Barclays from $90.00 to $93.00 in a research note issued to investors on Tuesday,Benzinga reports. They currently have an underweight rating on the stock.

Several other equities research analysts have also recently issued reports on CHD. Stifel Nicolaus lifted their target price on shares of Church & Dwight from $103.00 to $105.00 and gave the stock a “hold” rating in a research note on Monday. Royal Bank of Canada reissued a “sector perform” rating and issued a $105.00 price objective on shares of Church & Dwight in a report on Monday. Truist Financial upped their price objective on shares of Church & Dwight from $110.00 to $115.00 and gave the company a “buy” rating in a report on Monday. Wells Fargo & Company upped their price objective on shares of Church & Dwight from $113.00 to $115.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Finally, JPMorgan Chase & Co. upped their price objective on shares of Church & Dwight from $99.00 to $107.00 and gave the company an “underweight” rating in a report on Thursday, January 16th. Two research analysts have rated the stock with a sell rating, seven have given a hold rating and eight have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $111.53.

Church & Dwight Trading Down 1.7 %

Shares of CHD opened at $105.32 on Tuesday. Church & Dwight has a 52-week low of $96.09 and a 52-week high of $113.50. The company has a quick ratio of 1.24, a current ratio of 1.70 and a debt-to-equity ratio of 0.51. The firm’s fifty day moving average is $106.07 and its two-hundred day moving average is $104.30. The stock has a market cap of $25.80 billion, a PE ratio of 44.44, a price-to-earnings-growth ratio of 3.28 and a beta of 0.59.

Church & Dwight (NYSE:CHD) last announced its earnings results on Friday, January 31st. The company reported $0.77 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same quarter in the previous year, the firm posted $0.65 EPS. Research analysts forecast that Church & Dwight will post 3.7 earnings per share for the current fiscal year.

Church & Dwight Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 3rd. Stockholders of record on Friday, February 14th will be given a dividend of $0.295 per share. This represents a $1.18 annualized dividend and a dividend yield of 1.12%. The ex-dividend date of this dividend is Friday, February 14th. This is a boost from Church & Dwight’s previous quarterly dividend of $0.28. Church & Dwight’s dividend payout ratio is currently 47.68%.

Insider Transactions at Church & Dwight

In other news, Director Bradley C. Irwin sold 13,200 shares of the stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $107.44, for a total transaction of $1,418,208.00. Following the sale, the director now owns 37,169 shares of the company’s stock, valued at approximately $3,993,437.36. This represents a 26.21 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CAO Joseph James Longo sold 7,780 shares of the stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $112.44, for a total transaction of $874,783.20. Following the sale, the chief accounting officer now directly owns 400 shares in the company, valued at $44,976. This represents a 95.11 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 115,622 shares of company stock valued at $12,842,559. 1.40% of the stock is currently owned by corporate insiders.

Institutional Trading of Church & Dwight

Several hedge funds have recently added to or reduced their stakes in the company. State Street Corp raised its holdings in Church & Dwight by 8.0% in the third quarter. State Street Corp now owns 13,116,334 shares of the company’s stock valued at $1,373,542,000 after acquiring an additional 969,006 shares in the last quarter. Massachusetts Financial Services Co. MA raised its holdings in Church & Dwight by 5.7% in the third quarter. Massachusetts Financial Services Co. MA now owns 8,016,345 shares of the company’s stock valued at $839,472,000 after acquiring an additional 429,863 shares in the last quarter. Stifel Financial Corp raised its holdings in Church & Dwight by 0.5% in the third quarter. Stifel Financial Corp now owns 4,295,527 shares of the company’s stock valued at $449,830,000 after acquiring an additional 21,607 shares in the last quarter. Allspring Global Investments Holdings LLC raised its holdings in Church & Dwight by 5.5% in the third quarter. Allspring Global Investments Holdings LLC now owns 3,358,179 shares of the company’s stock valued at $351,668,000 after acquiring an additional 175,221 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in Church & Dwight by 3.5% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 1,448,584 shares of the company’s stock valued at $151,681,000 after acquiring an additional 49,082 shares in the last quarter. Institutional investors and hedge funds own 86.60% of the company’s stock.

About Church & Dwight

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.